logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/07/2025
The Euro against the Japanese Yen just touched the 172.00 level, currently trading at 172.00, up 0.10% on the day.
Latest
3 m ago
Anhui Construction Investment establishes a media technology company.
4 m ago
In June, the sales volume of Inventec amounted to 60.52 billion new Taiwan dollars.
5 m ago
The remnants of Typhoon "Danas" will bring heavy rain to Guangdong.
7 m ago
Hong Kong stocks fluctuate | The afternoon decline of insurance stocks expands, with New China Life Insurance (01336.HK) and China Pacific Insurance (02601.HK) both falling more than 4%.
7 m ago
Sinopharm Pharmaceutical: The application for approval of the listing of Lodechibai monoclonal antibody has been accepted by the National Medical Products Administration for the treatment of atopic dermatitis.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.